| http://www.w3.org/ns/prov#value | - Archemix Corp. and London-based GlaxoSmithKline plc agreed to discover, develop and commercialize aptamer therapeutics to treat inflammatory diseases, such as rheumatoid arthritis and inflammatory bowel disease, in a collaboration that gives Archemix $27.5 million up front. (BioWorld Today)
|
